US · guidance
CMS SOM App. A, Tag A-0510
§482.25(b)(8) - Information relating to drug interactions and information of
drug therapy, side effects, toxicology, dosage, indications for use, and routes
of administration must be available to the professional staff.
Interpretive Guidelines §482.25(b)(8)
The pharmacy must be a resource for medication-related information to the hospital’s health-care
practitioners and other health care personnel to optimize therapeutic outcomes and minimize
adverse drug events. Information must be available concerning drug interactions and
information of drug therapy, side effects, toxicology, dosage, indications for use, and routes of
administration. The pharmacy may also assist other health care professionals with the following
medication-related functions:
• Collection and organization of patient-specific information (height, weight, allergies);
• Identification of the presence of medication-therapy problems, both potential and actual,
such as drug-drug interactions, excessive doses;
• Identification and specification of pharmaco-therapeutic goals;
• Implementation of a monitoring plan in collaboration with the patient, if applicable, and
other health-care professionals;
• Monitoring the effects of the pharmacotherapeutic regimen – could include adjusting
doses based on lab values (i.e.: Coumadin dosing); or
• Redesigning the regimen and monitoring plan as indicated.
For example, practitioners may write an order for “pharmacy to dose” an antibiotic. The
pharmacist would then take patient-specific information, review the patient’s current medication
therapies for any problems, and then calculate the dose required to meet therapeutic goals.
Increasingly, as hospitals move to computerized physician-order entry (CPOE) of medication
orders, much of this consultation function (e.g.; dosage, path of administration, drug-drug
interactions and other contraindications, etc.) is built in to the electronic health record (EHR)
system. However, the pharmacy service remains responsible for the provision of accurate, up-to-date information to meet the needs of the hospital’s practitioners, nursing staff and patients.
The hospital must also have immediately available sufficient up-to-date reference material on
drug therapy, whether in electronic or hard copy format. A pharmacist also should be readily
available by telephone or other means to respond to questions from practitioners and nursing
personnel.
Survey Procedures §482.25(b)(8)
• Is drug information readily available to nurses and practitioners, whether in hard copy or
electronic format?
• If drug information is built in to the hospital’s EHR system, ask the pharmacy director
how the hospital ensures that the information is accurate and up-to-date;
• Ask practitioners whether needed reference information is available to them when
prescribing drugs;
• Ask nursing staff whether needed reference information is available to them when
administering drugs or biologicals and when monitoring patients for effects of medication
therapies.
History
Rev. 151, Issued: 11-20-15, Effective: 11-20-15, Implementation: 11-20-15
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
259aa70486d07f1aed37dbb2e680a424356f94e61b48e5cbca58cc96fc7b2a0a
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.